Skip to main content
David Laxson, MD, Cardiology, Edina, MN, M Health Fairview Lakes Medical Center

DavidLaxsonMDFACC, FAHA

Cardiology Edina, MN

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Dr. Laxson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Laxson's full profile

Already have an account?

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Interventional Cardiology, 1987 - 1988
  • University of Minnesota
    University of MinnesotaFellowship, Cardiovascular Disease, 1984 - 1987
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine, 1982 - 1984
  • University of Minnesota
    University of MinnesotaInternship, Internal Medicine, 1981 - 1982
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1981
  • Stanford University
    Stanford UniversityBS, With Distinction, 1973 - 1977

Certifications & Licensure

  • ID State Medical License
    ID State Medical License 2021 - 2024
  • MN State Medical License
    MN State Medical License 1982 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology
  • Fellow (FAHA) Council on Basic Cardiovascular Sciences American Heart Association
  • National Research Service Award National Institutes of Health, 1986
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Measurement of Shear-Activated Platelet Aggregate Formation in Non-anticoagulated Blood: Utility in Detection of Clopidogrel-Aspirin-Induced Platelet Dysfunction  
    G.J. Johnson, A.V. Sharda, G.H.R. Rao, M.H. Ereth, D.D. Laxson, W.G. Owen, Clinical and Applied Thrombosis/Hemostasis, 10/17/2011
  • Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A  
    TIMI 11A Investigators, JACC, 1/1/1997
  • Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR Study, a multicenter, double blind, placebo controlled trial ...  
    Faxson DP et al, J Am Coll Cardiol, 1/1/1995
  • Join now to see all

Abstracts/Posters

  • Measurement of Platelet Activation in Response to Shear Stress in Patients with Arterial Vascular Risk Factors and Disease.
    Gerhard JJ, Gundu HR, Raveendran G, Laxson DD, Helmer GA, Haworth B, Platelets International Sympsium, 10/15/2008
  • Are ACTs helpful in the management of anticoagulation with low molecular weight heparin?
    Henry TD, Knox LK, Iacarella CL, Laxson DD, J Am Coll Cardiol, 1/1/1997
  • Time course of reduction in adverse events following angioplasty using a IIb/IIIa receptor blocker, tirofiban: the RESTORE trial.
    King SB, Willerson JT, Ross AM, et al for the RESTORE Investigators, Circulation, 1/1/1996
  • Join now to see all

Professional Memberships

Hospital Affiliations